Want to join the conversation?
Pharmaceutical distributor $MCK reported 4Q16 net income attributable to the company of $431MM or $1.88 per share compared to $132MM or $0.56 per share in 4Q15. Revenues were $46.7Bil, up 4% compared to $44.9Bil a year ago. Adjusted earnings per diluted share was $2.44 in 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?